Free release
4-((5-Amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl)amino)benzenesulfonamide

4-((5-Amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl)amino)benzenesulfonamide

CAS No. :443797-96-4MDL No. :MFCD11100270Formula :C15H12F2N6O3SBoiling Point :-Linear Structure Formula :-InChI Key :KDK

Sales:Service@apichina.com
CAS No. :443797-96-4 Brand :Qitai
Formula :C15H12F2N6O3S M.W :394.36

Introduction

CAS No. :443797-96-4 MDL No. :MFCD11100270
Formula : C15H12F2N6O3S Boiling Point : -
Linear Structure Formula :- InChI Key :KDKUVYLMPJIGKA-UHFFFAOYSA-N
M.W : 394.36 Pubchem ID :5330790
Synonyms :
Aurora A Inhibitor I;Aurora Kinase/CDK Inhibitor
Chemical Name :4-((5-Amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl)amino)benzenesulfonamide

Physicochemical Properties

Num. heavy atoms : 27
Num. arom. heavy atoms : 17
Fraction Csp3 : 0.0
Num. rotatable bonds : 5
Num. H-bond acceptors : 8.0
Num. H-bond donors : 3.0
Molar Refractivity : 91.05
TPSA : 154.37 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.01 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.7
Log Po/w (XLOGP3) : 2.39
Log Po/w (WLOGP) : 3.15
Log Po/w (MLOGP) : 1.63
Log Po/w (SILICOS-IT) : -0.19
Consensus Log Po/w : 1.74

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 1.0
Egan : 1.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.93
Solubility : 0.0467 mg/ml ; 0.000118 mol/l
Class : Soluble
Log S (Ali) : -5.27
Solubility : 0.0021 mg/ml ; 0.00000533 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -4.76
Solubility : 0.00677 mg/ml ; 0.0000172 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.82
Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram: